Bioceres Crop Solutions Corp. (BIOX) Stock Forecast
Data as of Sep 16, 2026Basic Materials · Current price $0.39 (-3.49%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 2, 2026 | Austin Moeller | Canaccord Genuity | $2.00 | +412.3% |
| Sep 10, 2025 | Ben Klieve | Lake Street | $5.00 | +1180.7% |
| Oct 21, 2024 | Kristen Owen | Oppenheimer | $13.00 | +3229.9% |
| Sep 11, 2024 | Ben Klieve | Loop Capital Markets | $13.00 | +3229.9% |
| Sep 11, 2024 | Austin Moeller | Canaccord Genuity | $12.50 | +3101.8% |
| Sep 10, 2024 | Kristen Owen | Oppenheimer | $16.00 | +3998.4% |
| Jul 2, 2024 | Scott Fortune | Roth Capital | $15.00 | +3742.2% |
Top Analysts Covering BIOX
BIOX vs Sector & Market
| Metric | BIOX | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.35 | 2.42 |
| Analyst Count | 1 | 6 | 18 |
| Target Upside | +1850.7% | +130.6% | +19.5% |
| P/E Ratio | -0.13 | -8.09 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-06-30 | $379M | $379M | $379M | 1 |
| 2028-06-30 | $511M | $511M | $511M | 1 |
| 2029-06-30 | $579M | $579M | $579M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-06-30 | $0.05 | $0.05 | $0.05 | 1 |
| 2028-06-30 | $0.56 | $0.56 | $0.56 | 1 |
| 2029-06-30 | $0.82 | $0.82 | $0.82 | 1 |
Frequently Asked Questions
What is the analyst consensus for BIOX?
The consensus among 1 analysts covering Bioceres Crop Solutions Corp. (BIOX) is Hold with an average price target of $8.00.
What is the highest price target for BIOX?
The highest price target for BIOX is $16.00, set by Kristen Owen at Oppenheimer on 2024-09-10.
What is the lowest price target for BIOX?
The lowest price target for BIOX is $2.00, set by Austin Moeller at Canaccord Genuity on 2026-01-02.
How many analysts cover BIOX?
1 analysts have issued ratings for Bioceres Crop Solutions Corp. in the past 12 months.
Is BIOX a buy or sell right now?
Based on 1 analyst ratings, BIOX has a consensus rating of Hold (3.00/5) with a +1850.7% upside to the consensus target of $8.00.
What are the earnings estimates for BIOX?
Analysts estimate BIOX will report EPS of $0.05 for the period ending 2027-06-30, with revenue estimated at $379M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.